High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples